Monday, 5 Jan 2009 | Source: The Associated Press
Shares of Biogen Idec Inc. fell Monday after JP Morgan cut its rating on the stock, saying the multiple sclerosis drug Tysabri could continue facing challenges in 2009 while the company lacks any catalysts to drive new revenue.
Thursday, 30 Oct 2008 | Source: Reuters
Researchers combing the human gene map have found four more areas that affect the risk of Alzheimer's disease and believe the studies are starting to point to new and better treatments.
Friday, 1 Aug 2008 | Source: Reuters
Shares in Irish drugmaker Elan dived more than 50 percent to their lowest level since 2005 on Friday as a second product setback in a week shattered confidence in its line-up of biotech medicines.
Thursday, 31 Jul 2008 | Source: Reuters
Biogen Idec and Elan notified regulators of two confirmed cases of a potentially deadly brain disease in multiple sclerosis (MS) patients being treated with Tysabri.
Wednesday, 30 Jul 2008 | Source: CNBC.com
A new groundbreaking research that could potentially lead to cure Alzheimer's disease and on how Chesapeake's CEO hopes to move Americans away from "expensive imported oil" to natural gas. Following are today's top videos:
Baxter researchers unveiled positive mid-stage test results on an intravenous drug, Wednesday, which is already in late-stage development in a very small number of patients.
Wednesday, 30 Jul 2008 | Source: CNBC.com
Tuesday, 29 Jul 2008 | Source: Reuters
Keenly awaited details on Elan and Wyeth's new Alzheimer's drug bapineuzumab show it raised the risk of a potentially serious side effect, especially in people with a genetic risk of the disease, the companies said on Tuesday.
Posts |
COMPANY : Elan Corporation, plc
Elan is seeing extremely heavy options activity as its stock moves higher... Read More
7 Jan 2009
Don't look now, but in the first week of the new year shares of Elan stock lost nearly three-quarters of its value last year on safety concerns about the multiple sclerosis drug Tysabri, which it shares with Biogen Idec, and efficacy concerns over the Alzheimer's drug it's developing with Wyeth... Read More
8 Oct 2008
Since there should really be no compelling reason to blog or report on Dendreon and Provenge for quite awhile, here's one last hurrah... Read More
5 Sep 2008
Futures dropped 10 points as the unemployment rate rose .4 percent to 6.1 percent, the highest since September 2003... Read More
VIDEO | COMPANIES : Elan Corporation, plc
Can investors who lost everything in the Bernard Madoff case ever hope to recover anything? This enormous task will be t...
Discussing investor protection when they lose securities through fraud or when a firm collapses, with Stephen Harbeck, S...
Insight on Wall Street's $50 billion ponzi scheme, with Jerry Lynch, JFL Consulting; Stephen Harbeck, Securities Investo...
Weighing in on whether 2009 will be the year to buy a home, with Mark Vitner, Wachovia Corporation; Joe Lavorgna, Deutsc...
More Videos
HOME | NEWS | MARKETS | EARNINGS | INVESTING | VIDEO | CNBC TV | CNBC PLUS | CNBC MOBILE | CNBC HD+
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
About CNBC | Site Map | Privacy Policy | Terms of Service | Advertise | Help | Feedback | Video Reprints
Partners: AOL Money | BloggingStocks.com
(c) 2009 CNBC, Inc. All Rights Reserved
Data is a real-time snapshot *Data is delayed at least 15 minutes